News
Argireline vs Matrixyl : quel peptide topique o...
Argireline et Matrixyl sont deux peptides anti-âge populaires, mais lequel choisir ? Découvrez leurs mécanismes d'action, avantages et limites pour la peau québécoise.
Argireline vs Matrixyl : quel peptide topique o...
Argireline et Matrixyl sont deux peptides anti-âge populaires, mais lequel choisir ? Découvrez leurs mécanismes d'action, avantages et limites pour la peau québécoise.
Semaglutide Muscle Loss Regulatory Response: 20...
The FDA and EMA approved the first semaglutide-MOTS-c combination therapies in early 2025, responding to evidence that GLP-1 agonists accelerate muscle loss during weight reduction.
Semaglutide Muscle Loss Regulatory Response: 20...
The FDA and EMA approved the first semaglutide-MOTS-c combination therapies in early 2025, responding to evidence that GLP-1 agonists accelerate muscle loss during weight reduction.